bioMerieux's market cap is currently €13.49B. The company's EPS TTM is €1.35; its P/E ratio is 35.65; and it has a dividend yield of 0.80%. bioMerieux is scheduled to report earnings on September 4, 2025, and the estimated EPS forecast is €2.06. See an overview of income statement, balance sheet, and cash flow financials.
